Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of the Gastric Reactance (XL) in the Prediction of Morbimortality in Patients Post-operated of Elective Cardiac Surgery

NCT03799133 is registered in ClinicalTrials.gov with Critical Perfusion Inc. as lead sponsor.

NCT NCT03799133
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03799133 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of the Gastric Reactance (XL) in the Prediction of Morbimortality in Patients Post-operated of Elective Cardiac Surgery
Lead sponsor
Critical Perfusion Inc.
Phase
Not applicable
Overall status
Completed
Start date
September 26, 2018
Completion date
December 28, 2019
Enrollment
38 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac failure, valvular heart disease, ventricular dysfunction